Two Sigma Advisers’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,700
Closed -$523K 2061
2025
Q4
$523K Sell
6,700
-12,600
-65% -$1.02M ﹤0.01% 1759
2025
Q3
$1.64M Buy
19,300
+12,400
+180% +$993K ﹤0.01% 1223
2025
Q2
$540K Sell
6,900
-17,200
-71% -$1.27M ﹤0.01% 1714
2025
Q1
$1.74M Sell
24,100
-6,800
-22% -$571K ﹤0.01% 1214
2024
Q4
$2.74M Buy
30,900
+10,300
+50% +$918K 0.01% 979
2024
Q3
$1.74M Sell
20,600
-6,400
-24% -$568K ﹤0.01% 1145
2024
Q2
$2.5M Sell
27,000
-100
-0.4% -$10.1K 0.01% 1076
2024
Q1
$3.06M Sell
27,100
-19,100
-41% -$1.91M 0.01% 997
2023
Q4
$4.3M Buy
46,200
+8,200
+22% +$722K 0.01% 881
2023
Q3
$3.49M Buy
+38,000
New +$4.08M 0.01% 908
2022
Q4
Sell
-9,000
Closed -$684K 2709
2022
Q3
$684K Sell
9,000
-6,000
-40% -$577K ﹤0.01% 1710
2022
Q2
$1.64M Sell
15,000
-7,500
-33% -$796K ﹤0.01% 1320
2022
Q1
$2.24M Sell
22,500
-2,100
-9% -$200K 0.01% 1191
2021
Q4
$2.35M Sell
24,600
-4,500
-15% -$451K 0.01% 1111
2021
Q3
$3.22M Buy
29,100
+2,600
+10% +$296K 0.01% 999
2021
Q2
$3.07M Buy
26,500
+14,600
+123% +$1.68M 0.01% 1089
2021
Q1
$1.24M Buy
11,900
+5,600
+89% +$696K ﹤0.01% 1531
2020
Q4
$758K Buy
6,300
+3,000
+91% +$303K ﹤0.01% 1697
2020
Q3
$287K Sell
3,300
-11,500
-78% -$989K ﹤0.01% 2025
2020
Q2
$1.2M Buy
+14,800
New +$1.08M ﹤0.01% 1490
2020
Q1
Sell
-2,000
Closed -$229K 2576
2019
Q4
$229K Sell
2,000
-500
-20% -$62.3K ﹤0.01% 2145
2019
Q3
$326K Sell
2,500
-1,700
-40% -$221K ﹤0.01% 1893
2019
Q2
$515K Sell
4,200
-100
-2% -$11.5K ﹤0.01% 1801
2019
Q1
$452K Buy
4,300
+100
+2% +$10.7K ﹤0.01% 1833
2018
Q4
$430K Sell
4,200
-66
-2% -$7.33K ﹤0.01% 1831
2018
Q3
$506K Buy
4,266
+600
+16% +$67.8K ﹤0.01% 1796
2018
Q2
$352K Buy
+3,666
New +$340K ﹤0.01% 2050
2017
Q4
Sell
-3,966
Closed -$244K 2384
2017
Q3
$244K Sell
3,966
-2,100
-35% -$128K ﹤0.01% 1996
2017
Q2
$366K Buy
6,066
+200
+3% +$12.8K ﹤0.01% 1895
2017
Q1
$383K Sell
5,866
-300
-5% -$21.3K ﹤0.01% 2007
2016
Q4
$433K Buy
+6,166
New +$392K ﹤0.01% 1938
2015
Q4
Sell
-26,066
Closed -$1.17M 2028
2015
Q3
$1.17M Sell
26,066
-7,067
-21% -$352K 0.01% 949
2015
Q2
$1.81M Sell
33,133
-4,600
-12% -$228K 0.01% 852
2015
Q1
$1.79M Buy
37,733
+20,700
+122% +$880K 0.01% 824
2014
Q4
$715K Buy
17,033
+400
+2% +$15.7K 0.01% 1375
2014
Q3
$589K Sell
16,633
-1,200
-7% -$42.4K ﹤0.01% 1444
2014
Q2
$610K Buy
17,833
+67
+0.4% +$2.16K ﹤0.01% 1526
2014
Q1
$614K Sell
17,766
-567
-3% -$18.8K 0.01% 1446
2013
Q4
$647K Buy
18,333
+1,200
+7% +$39.3K 0.01% 1427
2013
Q3
$533K Buy
17,133
+1,167
+7% +$34.4K 0.01% 1340
2013
Q2
$442K Buy
+15,966
New +$422K 0.01% 1413

Other funds holding USPH

Two Sigma Advisers's USPH Position: Q1 2026 in Review

Two Sigma Advisers sold out of US Physical Therapy (USPH) in Q1 2026, closing a stake of 6,700 shares — an estimated $523K sold.

Two Sigma Advisers first reported a position in USPH in Q2 2013 and held it in 41 quarters. The position peaked at $4.3M in Q4 2023. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.

  • Two Sigma Advisers reported no remaining US Physical Therapy position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 6,700 US Physical Therapy shares in Q1 2026, an estimated $523K.
  • Two Sigma Advisers first reported a position in US Physical Therapy in Q2 2013 and held it in 41 quarters.
  • Two Sigma Advisers's US Physical Therapy position peaked at $4.3M in Q4 2023.
  • 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.